

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | short-term memory (GO:0007614) | 7.83965773 |
| 2 | regulation of apoptotic cell clearance (GO:2000425) | 7.68850314 |
| 3 | diterpenoid biosynthetic process (GO:0016102) | 7.66240506 |
| 4 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 7.60711397 |
| 5 | regulation of lipoprotein metabolic process (GO:0050746) | 7.34122825 |
| 6 | positive regulation of osteoblast proliferation (GO:0033690) | 6.91187485 |
| 7 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 6.74967107 |
| 8 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 6.32675440 |
| 9 | antigen processing and presentation via MHC class Ib (GO:0002475) | 6.16808504 |
| 10 | modulation by symbiont of host cellular process (GO:0044068) | 6.03353069 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.97412576 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.97412576 |
| 13 | regulation of clathrin-mediated endocytosis (GO:2000369) | 5.34512134 |
| 14 | terpenoid biosynthetic process (GO:0016114) | 5.10611455 |
| 15 | righting reflex (GO:0060013) | 4.98699262 |
| 16 | cellular response to electrical stimulus (GO:0071257) | 4.87248280 |
| 17 | phototransduction, visible light (GO:0007603) | 4.74283019 |
| 18 | retinol metabolic process (GO:0042572) | 4.73279492 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.71877086 |
| 20 | melanin biosynthetic process (GO:0042438) | 4.69545709 |
| 21 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.60492146 |
| 22 | retinal metabolic process (GO:0042574) | 4.54970720 |
| 23 | detection of light stimulus (GO:0009583) | 4.50265971 |
| 24 | retinoid metabolic process (GO:0001523) | 4.38192782 |
| 25 | detection of visible light (GO:0009584) | 4.35625671 |
| 26 | keratan sulfate catabolic process (GO:0042340) | 4.12248062 |
| 27 | melanin metabolic process (GO:0006582) | 4.11427494 |
| 28 | diterpenoid metabolic process (GO:0016101) | 4.10470129 |
| 29 | visual perception (GO:0007601) | 4.02120493 |
| 30 | polyol transport (GO:0015791) | 3.97045846 |
| 31 | sensory perception of light stimulus (GO:0050953) | 3.96884814 |
| 32 | modified amino acid transport (GO:0072337) | 3.90682175 |
| 33 | protein-chromophore linkage (GO:0018298) | 3.90230330 |
| 34 | quaternary ammonium group transport (GO:0015697) | 3.86585010 |
| 35 | secondary metabolite biosynthetic process (GO:0044550) | 3.76871462 |
| 36 | melanocyte differentiation (GO:0030318) | 3.76023615 |
| 37 | positive regulation of chemokine secretion (GO:0090197) | 3.74305322 |
| 38 | ketone body metabolic process (GO:1902224) | 3.69921811 |
| 39 | pigment cell differentiation (GO:0050931) | 3.58430066 |
| 40 | negative regulation of lipid storage (GO:0010888) | 3.57268236 |
| 41 | microglial cell activation (GO:0001774) | 3.55817627 |
| 42 | terpenoid metabolic process (GO:0006721) | 3.53679241 |
| 43 | negative chemotaxis (GO:0050919) | 3.52646379 |
| 44 | regulation of osteoblast proliferation (GO:0033688) | 3.50738383 |
| 45 | viral entry into host cell (GO:0046718) | 3.48876171 |
| 46 | sodium ion export (GO:0071436) | 3.48506726 |
| 47 | negative regulation of catenin import into nucleus (GO:0035414) | 3.47477104 |
| 48 | regulation of acrosome reaction (GO:0060046) | 3.45639632 |
| 49 | detection of external stimulus (GO:0009581) | 3.42531496 |
| 50 | camera-type eye morphogenesis (GO:0048593) | 3.36318921 |
| 51 | detection of abiotic stimulus (GO:0009582) | 3.34404269 |
| 52 | cellular sodium ion homeostasis (GO:0006883) | 3.32850273 |
| 53 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.29532791 |
| 54 | fat-soluble vitamin metabolic process (GO:0006775) | 3.29476643 |
| 55 | cell-cell junction maintenance (GO:0045217) | 3.26284210 |
| 56 | potassium ion import (GO:0010107) | 3.24635284 |
| 57 | ERK1 and ERK2 cascade (GO:0070371) | 3.24113475 |
| 58 | positive regulation of antigen processing and presentation (GO:0002579) | 3.20807351 |
| 59 | transepithelial transport (GO:0070633) | 3.19037712 |
| 60 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.18632836 |
| 61 | smooth muscle tissue development (GO:0048745) | 3.17034329 |
| 62 | chondroitin sulfate catabolic process (GO:0030207) | 3.13105564 |
| 63 | glycerophospholipid catabolic process (GO:0046475) | 3.10489010 |
| 64 | locomotory exploration behavior (GO:0035641) | 3.08334245 |
| 65 | regulation of ARF protein signal transduction (GO:0032012) | 3.04922835 |
| 66 | cellular potassium ion homeostasis (GO:0030007) | 3.00454443 |
| 67 | regulation of extracellular matrix disassembly (GO:0010715) | 2.93287861 |
| 68 | face development (GO:0060324) | 2.92725430 |
| 69 | response to pheromone (GO:0019236) | 2.92719954 |
| 70 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.91668379 |
| 71 | retinoic acid metabolic process (GO:0042573) | 2.89712646 |
| 72 | primary alcohol metabolic process (GO:0034308) | 2.89019218 |
| 73 | nerve growth factor signaling pathway (GO:0038180) | 2.88125269 |
| 74 | synaptic vesicle maturation (GO:0016188) | 2.88080019 |
| 75 | isoprenoid metabolic process (GO:0006720) | 2.88000842 |
| 76 | bicarbonate transport (GO:0015701) | 2.82888111 |
| 77 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.81377911 |
| 78 | negative regulation of hormone metabolic process (GO:0032351) | 2.81377911 |
| 79 | cellular component maintenance (GO:0043954) | 2.77764086 |
| 80 | mitochondrion distribution (GO:0048311) | 2.77569375 |
| 81 | regulation of chemokine secretion (GO:0090196) | 2.77158209 |
| 82 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.76104539 |
| 83 | inositol metabolic process (GO:0006020) | 2.74953531 |
| 84 | heterotypic cell-cell adhesion (GO:0034113) | 2.74459807 |
| 85 | cell junction maintenance (GO:0034331) | 2.73166949 |
| 86 | convergent extension (GO:0060026) | 2.73135118 |
| 87 | rhodopsin mediated signaling pathway (GO:0016056) | 2.71291256 |
| 88 | protein localization to endosome (GO:0036010) | 2.71232218 |
| 89 | endodermal cell differentiation (GO:0035987) | 2.70639091 |
| 90 | establishment of nucleus localization (GO:0040023) | 2.69941361 |
| 91 | response to auditory stimulus (GO:0010996) | 2.69694424 |
| 92 | sodium-independent organic anion transport (GO:0043252) | 2.68918626 |
| 93 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.67330037 |
| 94 | negative regulation of heart growth (GO:0061117) | 2.66573673 |
| 95 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.66573673 |
| 96 | layer formation in cerebral cortex (GO:0021819) | 2.65715306 |
| 97 | negative regulation of granulocyte differentiation (GO:0030853) | 2.63813756 |
| 98 | detection of temperature stimulus (GO:0016048) | 2.62597469 |
| 99 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.59979753 |
| 100 | macroautophagy (GO:0016236) | 2.59072646 |
| 101 | negative regulation of JUN kinase activity (GO:0043508) | 2.58253089 |
| 102 | L-amino acid import (GO:0043092) | 2.58234536 |
| 103 | gamma-aminobutyric acid transport (GO:0015812) | 2.56678472 |
| 104 | embryonic eye morphogenesis (GO:0048048) | 2.56415231 |
| 105 | regulation of microtubule polymerization (GO:0031113) | 2.54657924 |
| 106 | L-serine transport (GO:0015825) | 2.54375666 |
| 107 | interkinetic nuclear migration (GO:0022027) | 2.53525774 |
| 108 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.53455832 |
| 109 | peripheral nervous system axon ensheathment (GO:0032292) | 2.53188719 |
| 110 | myelination in peripheral nervous system (GO:0022011) | 2.53188719 |
| 111 | zinc ion transmembrane transport (GO:0071577) | 2.52625931 |
| 112 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.52620700 |
| 113 | entry into host cell (GO:0030260) | 2.51882092 |
| 114 | movement in environment of other organism involved in symbiotic interaction (GO:0052192) | 2.51882092 |
| 115 | entry into cell of other organism involved in symbiotic interaction (GO:0051806) | 2.51882092 |
| 116 | entry into host (GO:0044409) | 2.51882092 |
| 117 | entry into other organism involved in symbiotic interaction (GO:0051828) | 2.51882092 |
| 118 | movement in host environment (GO:0052126) | 2.51882092 |
| 119 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.51007260 |
| 120 | glomerular visceral epithelial cell development (GO:0072015) | 2.50261358 |
| 121 | response to electrical stimulus (GO:0051602) | 2.49275841 |
| 122 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.49115065 |
| 123 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.48256394 |
| 124 | mannose metabolic process (GO:0006013) | 2.47691691 |
| 125 | regulation of receptor biosynthetic process (GO:0010869) | 2.46712155 |
| 126 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.46517862 |
| 127 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.44556857 |
| 128 | phagocytosis, recognition (GO:0006910) | 2.44075415 |
| 129 | regulation of ARF GTPase activity (GO:0032312) | 2.43964705 |
| 130 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.42392373 |
| 131 | glycine transport (GO:0015816) | 2.42268148 |
| 132 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.42008276 |
| 133 | chemical homeostasis within a tissue (GO:0048875) | 2.40489586 |
| 134 | hyaluronan catabolic process (GO:0030214) | 2.39920458 |
| 135 | regulation of synapse structural plasticity (GO:0051823) | 2.39156961 |
| 136 | ear development (GO:0043583) | 2.38786011 |
| 137 | macrophage activation involved in immune response (GO:0002281) | 2.37969490 |
| 138 | neuroepithelial cell differentiation (GO:0060563) | 2.37863092 |
| 139 | stress fiber assembly (GO:0043149) | 2.36234032 |
| 140 | detection of light stimulus involved in visual perception (GO:0050908) | 2.35141534 |
| 141 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.35141534 |
| 142 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.34642112 |
| 143 | negative regulation of lipid transport (GO:0032369) | 2.34460594 |
| 144 | positive regulation of pseudopodium assembly (GO:0031274) | 2.34267873 |
| 145 | tyrosine metabolic process (GO:0006570) | 2.33412909 |
| 146 | regulation of antigen processing and presentation (GO:0002577) | 2.33197146 |
| 147 | myotube differentiation (GO:0014902) | 2.33093968 |
| 148 | amino acid import (GO:0043090) | 2.33079012 |
| 149 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.31501201 |
| 150 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.31427586 |
| 151 | ovulation cycle (GO:0042698) | 2.31286608 |
| 152 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.29714951 |
| 153 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.29649011 |
| 154 | proline transport (GO:0015824) | 2.28823806 |
| 155 | membrane repolarization (GO:0086009) | 2.28044052 |
| 156 | lung epithelium development (GO:0060428) | 2.25421754 |
| 157 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.24242354 |
| 158 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.23347595 |
| 159 | alanine transport (GO:0032328) | 2.21698447 |
| 160 | adaptation of signaling pathway (GO:0023058) | 2.19515099 |
| 161 | neuromuscular process controlling balance (GO:0050885) | 2.19012218 |
| 162 | negative regulation of inclusion body assembly (GO:0090084) | 2.15783707 |
| 163 | serine transport (GO:0032329) | 2.14757746 |
| 164 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.14596475 |
| 165 | membrane repolarization during action potential (GO:0086011) | 2.11715529 |
| 166 | keratan sulfate metabolic process (GO:0042339) | 2.11560301 |
| 167 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.09531532 |
| 168 | ruffle organization (GO:0031529) | 2.08844727 |
| 169 | cortical actin cytoskeleton organization (GO:0030866) | 2.08199051 |
| 170 | long-term memory (GO:0007616) | 2.05951445 |
| 171 | negative regulation of stress fiber assembly (GO:0051497) | 2.05922723 |
| 172 | synaptic vesicle endocytosis (GO:0048488) | 2.05441949 |
| 173 | peptidyl-threonine modification (GO:0018210) | 2.05413970 |
| 174 | positive regulation of Rap GTPase activity (GO:0032854) | 2.04462722 |
| 175 | glial cell migration (GO:0008347) | 2.04248203 |
| 176 | negative regulation of endocytosis (GO:0045806) | 2.03821870 |
| 177 | phototransduction (GO:0007602) | 2.03307685 |
| 178 | apoptotic cell clearance (GO:0043277) | 2.03091518 |
| 179 | vitamin A metabolic process (GO:0006776) | 11.9477057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.29332973 |
| 2 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.66517084 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 2.49724132 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.31753264 |
| 5 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.16880981 |
| 6 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.12800898 |
| 7 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.09383906 |
| 8 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.94699156 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89517923 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.88775906 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.87624918 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.87624918 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.87058553 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.86379082 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.80644977 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.79169890 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.79060754 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.76747835 |
| 19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.71825753 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.69510295 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65669714 |
| 22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.63680911 |
| 23 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.63629284 |
| 24 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.63629284 |
| 25 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.62254129 |
| 26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.62109722 |
| 27 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.59495241 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.59485402 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58417546 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.57800848 |
| 31 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57508235 |
| 32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.51942392 |
| 33 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.48542497 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.47660483 |
| 35 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.46279044 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45775832 |
| 37 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44351396 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41881712 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.41549667 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40236799 |
| 41 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.39077994 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37279770 |
| 43 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36745154 |
| 44 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.35614874 |
| 45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.32777469 |
| 46 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.29442077 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28851053 |
| 48 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28289965 |
| 49 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.27993179 |
| 50 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26952871 |
| 51 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26381536 |
| 52 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.26348010 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25698833 |
| 54 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.25619247 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24608293 |
| 56 | TP53_16413492_ChIP-PET_HCT116_Human | 1.23578032 |
| 57 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22041311 |
| 58 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21314542 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.21279477 |
| 60 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.20087721 |
| 61 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.20053193 |
| 62 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.19041305 |
| 63 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.16164569 |
| 64 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.15775905 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.15119849 |
| 66 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.14835786 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14755455 |
| 68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14337291 |
| 69 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.13802143 |
| 70 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13242496 |
| 71 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12670621 |
| 72 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.12207661 |
| 73 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12174453 |
| 74 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11036661 |
| 75 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.10546946 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09799197 |
| 77 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.09712719 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09637853 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09536587 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09519964 |
| 81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08810960 |
| 82 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08456021 |
| 83 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07750761 |
| 84 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06863866 |
| 85 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06470748 |
| 86 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05743142 |
| 87 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05279820 |
| 88 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.04811206 |
| 89 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.04778675 |
| 90 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04750147 |
| 91 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.03054395 |
| 92 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00554706 |
| 93 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00092519 |
| 94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99167478 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98492530 |
| 96 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98421088 |
| 97 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.98403218 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97953507 |
| 99 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97689548 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97684310 |
| 101 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.97540356 |
| 102 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97530761 |
| 103 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97510796 |
| 104 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96608329 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96431752 |
| 106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96133400 |
| 107 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.95738866 |
| 108 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94573516 |
| 109 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.94551766 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94338453 |
| 111 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.94123578 |
| 112 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93636923 |
| 113 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93163573 |
| 114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92802495 |
| 115 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92802495 |
| 116 | AR_19668381_ChIP-Seq_PC3_Human | 0.92050037 |
| 117 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91880508 |
| 118 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91790400 |
| 119 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91177717 |
| 120 | FUS_26573619_Chip-Seq_HEK293_Human | 0.91026310 |
| 121 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89814665 |
| 122 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89458065 |
| 123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88267572 |
| 124 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.88060975 |
| 125 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.88012625 |
| 126 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87888835 |
| 127 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.87775249 |
| 128 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.86946194 |
| 129 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86863308 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86727944 |
| 131 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86532775 |
| 132 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.86497055 |
| 133 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86356450 |
| 134 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.86267840 |
| 135 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.85937110 |
| 136 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85931242 |
| 137 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85266295 |
| 138 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84279867 |
| 139 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.84221390 |
| 140 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.83450977 |
| 141 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.81807406 |
| 142 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.81200442 |
| 143 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.81034836 |
| 144 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.80931912 |
| 145 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80750562 |
| 146 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.80538888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005257_abnormal_intraocular_pressure | 3.44273226 |
| 2 | MP0004019_abnormal_vitamin_homeostasis | 3.20890354 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.14675123 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.07072617 |
| 5 | MP0005248_abnormal_Harderian_gland | 2.95200709 |
| 6 | MP0000372_irregular_coat_pigmentation | 2.92018609 |
| 7 | MP0008004_abnormal_stomach_pH | 2.55317560 |
| 8 | MP0002090_abnormal_vision | 2.43504030 |
| 9 | MP0001324_abnormal_eye_pigmentation | 2.38008300 |
| 10 | MP0005551_abnormal_eye_electrophysiolog | 2.36388162 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.09173657 |
| 12 | MP0000465_gastrointestinal_hemorrhage | 2.03296415 |
| 13 | MP0003011_delayed_dark_adaptation | 10.6711435 |
| 14 | MP0005171_absent_coat_pigmentation | 1.99836192 |
| 15 | MP0004185_abnormal_adipocyte_glucose | 1.93892998 |
| 16 | MP0003172_abnormal_lysosome_physiology | 1.92237138 |
| 17 | MP0003690_abnormal_glial_cell | 1.88570649 |
| 18 | MP0005253_abnormal_eye_physiology | 1.83705227 |
| 19 | MP0005666_abnormal_adipose_tissue | 1.78301357 |
| 20 | MP0004885_abnormal_endolymph | 1.75296581 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.68507817 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.68197179 |
| 23 | MP0009384_cardiac_valve_regurgitation | 1.65633400 |
| 24 | MP0002638_abnormal_pupillary_reflex | 1.62817853 |
| 25 | MP0001958_emphysema | 1.59610055 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.59608856 |
| 27 | MP0003075_altered_response_to | 1.55641968 |
| 28 | MP0005408_hypopigmentation | 1.46922854 |
| 29 | MP0004858_abnormal_nervous_system | 1.46914203 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.43735088 |
| 31 | MP0004270_analgesia | 1.43178835 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.31715387 |
| 33 | MP0003635_abnormal_synaptic_transmissio | 1.31386528 |
| 34 | MP0000371_diluted_coat_color | 1.29975914 |
| 35 | MP0003303_peritoneal_inflammation | 1.29574585 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.29509679 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.29389533 |
| 38 | MP0001879_abnormal_lymphatic_vessel | 1.28165598 |
| 39 | MP0003045_fibrosis | 1.27602457 |
| 40 | MP0003136_yellow_coat_color | 1.27387645 |
| 41 | MP0003279_aneurysm | 1.27269415 |
| 42 | MP0006082_CNS_inflammation | 1.26770686 |
| 43 | MP0002653_abnormal_ependyma_morphology | 1.26322896 |
| 44 | MP0008961_abnormal_basal_metabolism | 1.25549087 |
| 45 | MP0005375_adipose_tissue_phenotype | 1.24098297 |
| 46 | MP0009840_abnormal_foam_cell | 1.22241793 |
| 47 | MP0005391_vision/eye_phenotype | 1.17520596 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.16723558 |
| 49 | MP0004130_abnormal_muscle_cell | 1.12165876 |
| 50 | MP0003633_abnormal_nervous_system | 1.11058202 |
| 51 | MP0003329_amyloid_beta_deposits | 1.06926033 |
| 52 | MP0005670_abnormal_white_adipose | 1.06209919 |
| 53 | MP0002928_abnormal_bile_duct | 1.05878149 |
| 54 | MP0002064_seizures | 1.04945792 |
| 55 | MP0002092_abnormal_eye_morphology | 1.04480755 |
| 56 | MP0004043_abnormal_pH_regulation | 1.04403400 |
| 57 | MP0005174_abnormal_tail_pigmentation | 1.00928704 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.00449336 |
| 59 | MP0003646_muscle_fatigue | 0.99295485 |
| 60 | MP0003091_abnormal_cell_migration | 0.98993675 |
| 61 | MP0002089_abnormal_postnatal_growth/wei | 0.97782830 |
| 62 | MP0003634_abnormal_glial_cell | 0.97046434 |
| 63 | MP0004381_abnormal_hair_follicle | 0.96840855 |
| 64 | MP0003183_abnormal_peptide_metabolism | 0.95665410 |
| 65 | MP0002168_other_aberrant_phenotype | 0.94530877 |
| 66 | MP0001186_pigmentation_phenotype | 0.94018851 |
| 67 | MP0003566_abnormal_cell_adhesion | 0.93899244 |
| 68 | MP0005275_abnormal_skin_tensile | 0.92415041 |
| 69 | MP0002063_abnormal_learning/memory/cond | 0.91914053 |
| 70 | * MP0005195_abnormal_posterior_eye | 0.90521986 |
| 71 | MP0005187_abnormal_penis_morphology | 0.88351112 |
| 72 | MP0003283_abnormal_digestive_organ | 0.87832525 |
| 73 | MP0003631_nervous_system_phenotype | 0.85262918 |
| 74 | MP0005377_hearing/vestibular/ear_phenot | 0.84224871 |
| 75 | MP0003878_abnormal_ear_physiology | 0.84224871 |
| 76 | MP0004272_abnormal_basement_membrane | 0.81752833 |
| 77 | * MP0002229_neurodegeneration | 0.81153953 |
| 78 | MP0000003_abnormal_adipose_tissue | 0.80724760 |
| 79 | MP0001501_abnormal_sleep_pattern | 0.79754029 |
| 80 | MP0008569_lethality_at_weaning | 0.78474176 |
| 81 | MP0006072_abnormal_retinal_apoptosis | 0.77477881 |
| 82 | MP0005197_abnormal_uvea_morphology | 0.76749914 |
| 83 | MP0002095_abnormal_skin_pigmentation | 0.75495241 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 0.73285693 |
| 85 | MP0001486_abnormal_startle_reflex | 0.73031586 |
| 86 | MP0000015_abnormal_ear_pigmentation | 0.71876845 |
| 87 | MP0003252_abnormal_bile_duct | 0.71104533 |
| 88 | MP0001299_abnormal_eye_distance/ | 0.70748642 |
| 89 | MP0010234_abnormal_vibrissa_follicle | 0.70465971 |
| 90 | MP0002075_abnormal_coat/hair_pigmentati | 0.70005635 |
| 91 | MP0005166_decreased_susceptibility_to | 0.67939067 |
| 92 | MP0004484_altered_response_of | 0.67837735 |
| 93 | MP0002998_abnormal_bone_remodeling | 0.67486758 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.67178058 |
| 95 | MP0000604_amyloidosis | 0.65136222 |
| 96 | MP0001177_atelectasis | 0.65127537 |
| 97 | MP0003632_abnormal_nervous_system | 0.64125041 |
| 98 | MP0000462_abnormal_digestive_system | 0.63896333 |
| 99 | MP0000920_abnormal_myelination | 0.62421427 |
| 100 | MP0002736_abnormal_nociception_after | 0.61423011 |
| 101 | MP0000534_abnormal_ureter_morphology | 0.61341848 |
| 102 | MP0005503_abnormal_tendon_morphology | 0.59153914 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.59131258 |
| 104 | MP0010030_abnormal_orbit_morphology | 0.57950781 |
| 105 | MP0002102_abnormal_ear_morphology | 0.57784745 |
| 106 | MP0001915_intracranial_hemorrhage | 0.57434183 |
| 107 | MP0002734_abnormal_mechanical_nocicepti | 0.57407867 |
| 108 | MP0000685_abnormal_immune_system | 0.56827389 |
| 109 | * MP0002882_abnormal_neuron_morphology | 0.56689177 |
| 110 | MP0004510_myositis | 0.55681604 |
| 111 | MP0008874_decreased_physiological_sensi | 0.55068732 |
| 112 | MP0002572_abnormal_emotion/affect_behav | 0.54983244 |
| 113 | MP0001502_abnormal_circadian_rhythm | 0.54785814 |
| 114 | MP0003879_abnormal_hair_cell | 0.54764781 |
| 115 | MP0000566_synostosis | 0.54497310 |
| 116 | MP0009745_abnormal_behavioral_response | 0.54172929 |
| 117 | MP0010368_abnormal_lymphatic_system | 0.53429670 |
| 118 | MP0002557_abnormal_social/conspecific_i | 0.53236273 |
| 119 | MP0002933_joint_inflammation | 0.52516547 |
| 120 | MP0004233_abnormal_muscle_weight | 0.52051129 |
| 121 | MP0008775_abnormal_heart_ventricle | 0.51317424 |
| 122 | MP0004084_abnormal_cardiac_muscle | 0.48346496 |
| 123 | MP0000751_myopathy | 0.46753845 |
| 124 | MP0005193_abnormal_anterior_eye | 0.45460961 |
| 125 | MP0001661_extended_life_span | 0.45091770 |
| 126 | * MP0002752_abnormal_somatic_nervous | 0.44651288 |
| 127 | MP0010386_abnormal_urinary_bladder | 0.42786438 |
| 128 | MP0000747_muscle_weakness | 0.42050908 |
| 129 | MP0003385_abnormal_body_wall | 0.40611069 |
| 130 | MP0005220_abnormal_exocrine_pancreas | 0.40398621 |
| 131 | MP0004036_abnormal_muscle_relaxation | 0.37273282 |
| 132 | MP0002938_white_spotting | 0.37037358 |
| 133 | MP0005409_darkened_coat_color | 0.36999305 |
| 134 | MP0002971_abnormal_brown_adipose | 0.34782032 |
| 135 | MP0010352_gastrointestinal_tract_polyps | 0.33913438 |
| 136 | MP0005023_abnormal_wound_healing | 0.33293445 |
| 137 | MP0000383_abnormal_hair_follicle | 0.33206647 |
| 138 | MP0005508_abnormal_skeleton_morphology | 0.32879846 |
| 139 | MP0006138_congestive_heart_failure | 0.32834876 |
| 140 | MP0005623_abnormal_meninges_morphology | 0.31390482 |
| 141 | MP0000749_muscle_degeneration | 0.30394899 |
| 142 | MP0002295_abnormal_pulmonary_circulatio | 0.29057239 |
| 143 | MP0000367_abnormal_coat/_hair | 0.28432724 |
| 144 | MP0000013_abnormal_adipose_tissue | 0.28031905 |
| 145 | MP0002233_abnormal_nose_morphology | 0.27708782 |
| 146 | MP0003828_pulmonary_edema | 0.27058773 |
| 147 | MP0001485_abnormal_pinna_reflex | 0.25872164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 8.16432613 |
| 2 | Ulnar claw (HP:0001178) | 6.92275855 |
| 3 | * Choroideremia (HP:0001139) | 5.55209531 |
| 4 | Segmental peripheral demyelination/remyelination (HP:0003481) | 5.27572780 |
| 5 | Vertebral compression fractures (HP:0002953) | 5.26569120 |
| 6 | Termporal pattern (HP:0011008) | 5.09811298 |
| 7 | Insidious onset (HP:0003587) | 5.09811298 |
| 8 | Peripheral hypomyelination (HP:0007182) | 4.84036895 |
| 9 | Upper limb muscle weakness (HP:0003484) | 4.79721734 |
| 10 | Arterial tortuosity (HP:0005116) | 4.76297500 |
| 11 | Abnormal pupillary function (HP:0007686) | 4.63294668 |
| 12 | Complement deficiency (HP:0004431) | 4.63260968 |
| 13 | Congenital stationary night blindness (HP:0007642) | 4.55296616 |
| 14 | Vascular tortuosity (HP:0004948) | 4.48271398 |
| 15 | Biconcave vertebral bodies (HP:0004586) | 4.33647117 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 4.27594119 |
| 17 | Attenuation of retinal blood vessels (HP:0007843) | 4.24625572 |
| 18 | Mutism (HP:0002300) | 4.24156525 |
| 19 | Cerebral aneurysm (HP:0004944) | 4.16852455 |
| 20 | Beaking of vertebral bodies (HP:0004568) | 4.16792344 |
| 21 | Decreased central vision (HP:0007663) | 4.16733332 |
| 22 | * Hypopigmentation of the fundus (HP:0007894) | 3.96808525 |
| 23 | Aortic aneurysm (HP:0004942) | 3.94527924 |
| 24 | Dyschromatopsia (HP:0007641) | 3.94374066 |
| 25 | Action tremor (HP:0002345) | 3.88889252 |
| 26 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.79948295 |
| 27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.79948295 |
| 28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.79948295 |
| 29 | Nonprogressive disorder (HP:0003680) | 3.47460837 |
| 30 | Glomerulonephritis (HP:0000099) | 3.38323428 |
| 31 | Aortic dissection (HP:0002647) | 3.31697805 |
| 32 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.23150516 |
| 33 | Dysostosis multiplex (HP:0000943) | 3.22996944 |
| 34 | Increased corneal curvature (HP:0100692) | 3.11679636 |
| 35 | Keratoconus (HP:0000563) | 3.11679636 |
| 36 | Scotoma (HP:0000575) | 3.11336121 |
| 37 | Abnormality of complement system (HP:0005339) | 3.05268796 |
| 38 | Hypoplasia of the iris (HP:0007676) | 3.03943526 |
| 39 | Intention tremor (HP:0002080) | 3.03913455 |
| 40 | Neurofibrillary tangles (HP:0002185) | 3.01186634 |
| 41 | Orthostatic hypotension (HP:0001278) | 3.00873331 |
| 42 | Progressive sensorineural hearing impairment (HP:0000408) | 2.98086339 |
| 43 | Abolished electroretinogram (ERG) (HP:0000550) | 2.96970738 |
| 44 | Subcapsular cataract (HP:0000523) | 2.93966857 |
| 45 | White forelock (HP:0002211) | 2.93275512 |
| 46 | Retinal atrophy (HP:0001105) | 2.90365321 |
| 47 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.87777474 |
| 48 | Hypoplasia of the fovea (HP:0007750) | 2.87777474 |
| 49 | Impaired proprioception (HP:0010831) | 2.87438854 |
| 50 | Postural tremor (HP:0002174) | 2.70643862 |
| 51 | Photophobia (HP:0000613) | 2.69703782 |
| 52 | Cardiovascular calcification (HP:0011915) | 2.67116861 |
| 53 | Hand muscle atrophy (HP:0009130) | 2.65817426 |
| 54 | Shallow orbits (HP:0000586) | 2.65224680 |
| 55 | Vascular calcification (HP:0004934) | 2.65122160 |
| 56 | * Bony spicule pigmentary retinopathy (HP:0007737) | 2.64039413 |
| 57 | Cerebral inclusion bodies (HP:0100314) | 2.62176198 |
| 58 | Neuronal loss in central nervous system (HP:0002529) | 2.61198637 |
| 59 | Striae distensae (HP:0001065) | 2.59265308 |
| 60 | * Abnormality of the fovea (HP:0000493) | 2.56306342 |
| 61 | Patchy hypopigmentation of hair (HP:0011365) | 2.55090844 |
| 62 | Subacute progressive viral hepatitis (HP:0006572) | 2.51630091 |
| 63 | Cone-rod dystrophy (HP:0000548) | 2.47717036 |
| 64 | Pendular nystagmus (HP:0012043) | 2.46735388 |
| 65 | Steppage gait (HP:0003376) | 2.45720014 |
| 66 | Blue irides (HP:0000635) | 2.45676060 |
| 67 | Ocular albinism (HP:0001107) | 2.44606413 |
| 68 | Myokymia (HP:0002411) | 2.43886754 |
| 69 | Distal upper limb amyotrophy (HP:0007149) | 2.42813475 |
| 70 | Upper limb amyotrophy (HP:0009129) | 2.42813475 |
| 71 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.42704073 |
| 72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.42704073 |
| 73 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.42704073 |
| 74 | Spondylolisthesis (HP:0003302) | 2.42199969 |
| 75 | Hemorrhage of the eye (HP:0011885) | 2.41846171 |
| 76 | Mucopolysacchariduria (HP:0008155) | 2.40978428 |
| 77 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.40978428 |
| 78 | Hemiparesis (HP:0001269) | 2.39613846 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 2.39380769 |
| 80 | Increased CSF protein (HP:0002922) | 2.38645816 |
| 81 | Supranuclear gaze palsy (HP:0000605) | 2.38109793 |
| 82 | Hepatoblastoma (HP:0002884) | 2.38051531 |
| 83 | Mitral valve prolapse (HP:0001634) | 2.37739223 |
| 84 | Constricted visual fields (HP:0001133) | 2.37278799 |
| 85 | Disproportionate tall stature (HP:0001519) | 2.36597106 |
| 86 | Ventricular fibrillation (HP:0001663) | 2.36037562 |
| 87 | Postural instability (HP:0002172) | 2.35660197 |
| 88 | Macular degeneration (HP:0000608) | 2.32726345 |
| 89 | Obstructive sleep apnea (HP:0002870) | 2.32587001 |
| 90 | Hemiplegia (HP:0002301) | 2.28578708 |
| 91 | Severe visual impairment (HP:0001141) | 2.27134839 |
| 92 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.26161221 |
| 93 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.25892598 |
| 94 | Central scotoma (HP:0000603) | 2.20624857 |
| 95 | Annular pancreas (HP:0001734) | 2.19799706 |
| 96 | Cardiomegaly (HP:0001640) | 2.19178624 |
| 97 | Onion bulb formation (HP:0003383) | 2.18534421 |
| 98 | Nephritis (HP:0000123) | 2.18159708 |
| 99 | Hammertoe (HP:0001765) | 2.11999027 |
| 100 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.11476639 |
| 101 | Abnormality of macular pigmentation (HP:0008002) | 2.10377654 |
| 102 | Foot dorsiflexor weakness (HP:0009027) | 2.08086954 |
| 103 | Aneurysm (HP:0002617) | 2.07698196 |
| 104 | Progressive neurologic deterioration (HP:0002344) | 2.07356799 |
| 105 | Coxa vara (HP:0002812) | 2.05241530 |
| 106 | Decreased motor nerve conduction velocity (HP:0003431) | 2.04326603 |
| 107 | Arnold-Chiari malformation (HP:0002308) | 2.03880086 |
| 108 | Iris hypopigmentation (HP:0007730) | 2.03490257 |
| 109 | Protrusio acetabuli (HP:0003179) | 1.99017561 |
| 110 | Peripheral demyelination (HP:0011096) | 1.97422371 |
| 111 | Polar cataract (HP:0010696) | 1.96940631 |
| 112 | Facial shape deformation (HP:0011334) | 1.96803139 |
| 113 | Potter facies (HP:0002009) | 1.96803139 |
| 114 | Hematochezia (HP:0002573) | 1.95998112 |
| 115 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.95364351 |
| 116 | Aplasia of the phalanges of the hand (HP:0009802) | 1.95364351 |
| 117 | Aplasia involving bones of the extremities (HP:0009825) | 1.95364351 |
| 118 | Epidermoid cyst (HP:0200040) | 1.92392967 |
| 119 | Hyperphosphatemia (HP:0002905) | 1.87004578 |
| 120 | Abnormality of the foot musculature (HP:0001436) | 1.86281652 |
| 121 | Amyloidosis (HP:0011034) | 1.85589884 |
| 122 | Clumsiness (HP:0002312) | 1.84931702 |
| 123 | Absent frontal sinuses (HP:0002688) | 1.84720082 |
| 124 | Urethral obstruction (HP:0000796) | 1.84429067 |
| 125 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.84174854 |
| 126 | Stereotypic behavior (HP:0000733) | 1.83975553 |
| 127 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.83234955 |
| 128 | Urinary incontinence (HP:0000020) | 1.81695374 |
| 129 | Soft skin (HP:0000977) | 1.78406630 |
| 130 | Erectile abnormalities (HP:0100639) | 1.76713031 |
| 131 | Cervical subluxation (HP:0003308) | 1.75470957 |
| 132 | Achilles tendon contracture (HP:0001771) | 1.74657322 |
| 133 | Type II diabetes mellitus (HP:0005978) | 1.73224654 |
| 134 | Asymmetric septal hypertrophy (HP:0001670) | 1.72296732 |
| 135 | Dementia (HP:0000726) | 1.71520068 |
| 136 | Dilatation of the ascending aorta (HP:0005111) | 1.70076454 |
| 137 | Abnormality of the acetabulum (HP:0003170) | 1.68071614 |
| 138 | Horizontal nystagmus (HP:0000666) | 1.67563443 |
| 139 | Diplopia (HP:0000651) | 1.66603857 |
| 140 | Abnormality of binocular vision (HP:0011514) | 1.66603857 |
| 141 | Thyroiditis (HP:0100646) | 1.66434470 |
| 142 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.66203564 |
| 143 | Lower limb asymmetry (HP:0100559) | 1.65698523 |
| 144 | Zonular cataract (HP:0010920) | 1.65696156 |
| 145 | Camptodactyly of toe (HP:0001836) | 1.64215087 |
| 146 | Bell-shaped thorax (HP:0001591) | 1.63915965 |
| 147 | Pigmentary retinal degeneration (HP:0001146) | 1.63238957 |
| 148 | Facial diplegia (HP:0001349) | 1.61778210 |
| 149 | Premature graying of hair (HP:0002216) | 1.61525522 |
| 150 | Interstitial pulmonary disease (HP:0006530) | 1.61285611 |
| 151 | Abnormality of the pupil (HP:0000615) | 1.59917933 |
| 152 | Generalized hypopigmentation (HP:0007513) | 1.59467906 |
| 153 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.59415290 |
| 154 | Osteolytic defects of the hand bones (HP:0009699) | 1.59415290 |
| 155 | Progressive hearing impairment (HP:0001730) | 1.56897024 |
| 156 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.56816706 |
| 157 | Persistence of primary teeth (HP:0006335) | 1.55903834 |
| 158 | Congenital sensorineural hearing impairment (HP:0008527) | 1.52924201 |
| 159 | Syringomyelia (HP:0003396) | 1.52414241 |
| 160 | Spinal cord lesions (HP:0100561) | 1.52414241 |
| 161 | Retinitis pigmentosa (HP:0000510) | 1.52006490 |
| 162 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.46709787 |
| 163 | Flared iliac wings (HP:0002869) | 1.46095909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.35742172 |
| 2 | GRK1 | 3.42011559 |
| 3 | MET | 3.39033148 |
| 4 | MAPK15 | 2.95975648 |
| 5 | MAP3K9 | 2.74070601 |
| 6 | KSR2 | 2.52641229 |
| 7 | TRPM7 | 2.44568995 |
| 8 | TRIB3 | 2.41616931 |
| 9 | PRKD3 | 2.33882126 |
| 10 | LATS1 | 2.15308180 |
| 11 | LATS2 | 2.13263581 |
| 12 | EEF2K | 2.07639498 |
| 13 | BLK | 2.03804776 |
| 14 | PKN2 | 2.03403837 |
| 15 | MYLK | 1.97198437 |
| 16 | STK24 | 1.92460902 |
| 17 | CAMK1D | 1.87421879 |
| 18 | PAK6 | 1.83593502 |
| 19 | MARK3 | 1.82102054 |
| 20 | TGFBR1 | 1.77225783 |
| 21 | CAMK1G | 1.73230747 |
| 22 | MAP3K6 | 1.65437957 |
| 23 | CSF1R | 1.62898587 |
| 24 | RIPK1 | 1.57853221 |
| 25 | RET | 1.53852216 |
| 26 | TIE1 | 1.52750032 |
| 27 | DMPK | 1.44082127 |
| 28 | LMTK2 | 1.41572192 |
| 29 | CAMKK1 | 1.38995994 |
| 30 | STK38 | 1.35329952 |
| 31 | PTK6 | 1.33598919 |
| 32 | BRD4 | 1.33108515 |
| 33 | TEC | 1.32475888 |
| 34 | TAOK1 | 1.30501100 |
| 35 | MUSK | 1.29081894 |
| 36 | SIK1 | 1.27028262 |
| 37 | ERN1 | 1.26308308 |
| 38 | NTRK2 | 1.20814318 |
| 39 | NEK9 | 1.11825992 |
| 40 | PAK4 | 1.11629706 |
| 41 | WNK4 | 1.08214981 |
| 42 | MOS | 1.07328172 |
| 43 | TYRO3 | 1.07292492 |
| 44 | GRK7 | 1.07015866 |
| 45 | TAOK3 | 1.06738193 |
| 46 | EPHA3 | 1.06301856 |
| 47 | PAK2 | 1.05720313 |
| 48 | KSR1 | 1.05307154 |
| 49 | PDGFRA | 1.04931504 |
| 50 | TSSK6 | 1.04377026 |
| 51 | EPHB2 | 1.03992572 |
| 52 | CSNK1A1L | 1.03801060 |
| 53 | MAP3K4 | 1.03402027 |
| 54 | PDK1 | 1.02876232 |
| 55 | ABL2 | 1.01653072 |
| 56 | DDR2 | 1.01539271 |
| 57 | FGFR2 | 1.01106003 |
| 58 | WNK1 | 1.00609243 |
| 59 | OBSCN | 0.98699075 |
| 60 | EPHA4 | 0.97582084 |
| 61 | MAP3K13 | 0.95141681 |
| 62 | DYRK1A | 0.94960292 |
| 63 | MINK1 | 0.94405787 |
| 64 | PRKCH | 0.94323492 |
| 65 | PHKG2 | 0.90967077 |
| 66 | PHKG1 | 0.90967077 |
| 67 | JAK2 | 0.90878405 |
| 68 | PDPK1 | 0.88869390 |
| 69 | NTRK1 | 0.88116967 |
| 70 | NTRK3 | 0.87448419 |
| 71 | PDK2 | 0.87324193 |
| 72 | ERBB4 | 0.85669859 |
| 73 | JAK1 | 0.85113315 |
| 74 | MAPK12 | 0.84971872 |
| 75 | RIPK4 | 0.84223464 |
| 76 | STK39 | 0.83943421 |
| 77 | CSNK1G2 | 0.83240435 |
| 78 | MAPK7 | 0.82688869 |
| 79 | MAP3K2 | 0.82084314 |
| 80 | STK10 | 0.79518337 |
| 81 | CSNK1G1 | 0.79043875 |
| 82 | MAP2K4 | 0.78628963 |
| 83 | MAPKAPK5 | 0.75680002 |
| 84 | SGK3 | 0.73413334 |
| 85 | FRK | 0.71290824 |
| 86 | MELK | 0.69931381 |
| 87 | EPHB1 | 0.69174415 |
| 88 | CSNK1G3 | 0.68223820 |
| 89 | DYRK1B | 0.66708574 |
| 90 | STK3 | 0.65521152 |
| 91 | STK38L | 0.63555904 |
| 92 | PTK2B | 0.63545055 |
| 93 | SGK494 | 0.63197064 |
| 94 | SGK223 | 0.63197064 |
| 95 | BMX | 0.62984006 |
| 96 | TYK2 | 0.62823651 |
| 97 | CAMK4 | 0.62669759 |
| 98 | CDK5 | 0.61896307 |
| 99 | STK11 | 0.61403465 |
| 100 | RAF1 | 0.61129459 |
| 101 | MARK2 | 0.59238206 |
| 102 | BTK | 0.58036475 |
| 103 | UHMK1 | 0.57596244 |
| 104 | GRK5 | 0.57420707 |
| 105 | SGK2 | 0.56641207 |
| 106 | PDGFRB | 0.56153782 |
| 107 | CCNB1 | 0.56089092 |
| 108 | CAMKK2 | 0.55971098 |
| 109 | PRKD1 | 0.55788031 |
| 110 | SYK | 0.55328034 |
| 111 | ICK | 0.53909533 |
| 112 | PINK1 | 0.52973981 |
| 113 | ADRBK1 | 0.52351657 |
| 114 | PRKAA1 | 0.51725435 |
| 115 | PRKCZ | 0.50446807 |
| 116 | PAK3 | 0.48410092 |
| 117 | PRKCE | 0.47688512 |
| 118 | PRKD2 | 0.47437639 |
| 119 | MAPKAPK3 | 0.47087980 |
| 120 | MST1R | 0.46660796 |
| 121 | MARK1 | 0.46389657 |
| 122 | ROCK2 | 0.45941956 |
| 123 | CSK | 0.45588423 |
| 124 | CAMK1 | 0.44118683 |
| 125 | PRKAA2 | 0.43836802 |
| 126 | GSK3A | 0.43406528 |
| 127 | INSR | 0.43257385 |
| 128 | CDK12 | 0.42686574 |
| 129 | OXSR1 | 0.42436666 |
| 130 | TTN | 0.42290268 |
| 131 | MAP3K7 | 0.42045986 |
| 132 | TTK | 0.41968307 |
| 133 | FER | 0.41384498 |
| 134 | TESK2 | 0.41191706 |
| 135 | HCK | 0.39880612 |
| 136 | SGK1 | 0.39791389 |
| 137 | MAPK13 | 0.37505921 |
| 138 | PTK2 | 0.37132967 |
| 139 | PKN1 | 0.36742910 |
| 140 | SIK2 | 0.36646873 |
| 141 | MTOR | 0.36560377 |
| 142 | CSNK1D | 0.34763452 |
| 143 | CDK9 | 0.34221094 |
| 144 | AKT2 | 0.33917005 |
| 145 | PRKCD | 0.32049637 |
| 146 | ABL1 | 0.30808432 |
| 147 | PRKACA | 0.30003962 |
| 148 | MAP2K7 | 0.29695106 |
| 149 | FES | 0.28913932 |
| 150 | DYRK3 | 0.28475980 |
| 151 | MAPK3 | 0.24412241 |
| 152 | IRAK1 | 0.23969456 |
| 153 | ROCK1 | 0.23456580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.18310045 |
| 2 | Histidine metabolism_Homo sapiens_hsa00340 | 3.13111942 |
| 3 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.01319536 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.27892807 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.24876570 |
| 6 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.22378911 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.21806405 |
| 8 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.13175571 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.08484762 |
| 10 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.86254426 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 1.82752508 |
| 12 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.69324414 |
| 13 | Circadian rhythm_Homo sapiens_hsa04710 | 1.66690316 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.57115591 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.56901208 |
| 16 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.51521036 |
| 17 | Prion diseases_Homo sapiens_hsa05020 | 1.51257615 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.44826662 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.43094439 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37091042 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.34537290 |
| 22 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.29214350 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27599396 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.27401897 |
| 25 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24481986 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.23510984 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.21712401 |
| 28 | Long-term potentiation_Homo sapiens_hsa04720 | 1.21514316 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.19306794 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.16271190 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.14970028 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.14029969 |
| 33 | Circadian entrainment_Homo sapiens_hsa04713 | 1.13826594 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10019948 |
| 35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.08163768 |
| 36 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.07252118 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07109127 |
| 38 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.06152223 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.05651311 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03533695 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02652331 |
| 42 | Melanoma_Homo sapiens_hsa05218 | 1.02378314 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.00691789 |
| 44 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.97066859 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95811486 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95178551 |
| 47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94992942 |
| 48 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.94928023 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 0.94642038 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94008461 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.93861988 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92448709 |
| 53 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90747786 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90685769 |
| 55 | GABAergic synapse_Homo sapiens_hsa04727 | 0.90392910 |
| 56 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.89331728 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.88665955 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88264484 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87966500 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87937334 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87756509 |
| 62 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86939114 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86577166 |
| 64 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.85368454 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85086228 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85081441 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.84036869 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 0.83458451 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.82591250 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81680965 |
| 71 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81276010 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80288638 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80176374 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79895288 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.79544663 |
| 76 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.77704322 |
| 77 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.77563357 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75583969 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74987531 |
| 80 | Insulin secretion_Homo sapiens_hsa04911 | 0.72897664 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72760223 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.72126718 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72121699 |
| 84 | Long-term depression_Homo sapiens_hsa04730 | 0.71508180 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70560219 |
| 86 | Cocaine addiction_Homo sapiens_hsa05030 | 0.69523090 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69066513 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68252139 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68073867 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.67953571 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67702480 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66485372 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66296264 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.65886133 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64911345 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64680145 |
| 97 | Gap junction_Homo sapiens_hsa04540 | 0.63348133 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62991872 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62397475 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.62370597 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62070384 |
| 102 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61889565 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60942889 |
| 104 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60587604 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60018185 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.59515504 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59085306 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58862544 |
| 109 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57846952 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57633467 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.57315451 |
| 112 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57202878 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.57161787 |
| 114 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57154669 |
| 115 | Axon guidance_Homo sapiens_hsa04360 | 0.57120338 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57074523 |
| 117 | Nicotine addiction_Homo sapiens_hsa05033 | 0.56779321 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55476219 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54500351 |
| 120 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.53698213 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53622448 |
| 122 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53073597 |
| 123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52933163 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52907097 |
| 125 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52746610 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.52680562 |
| 127 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52616559 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52464630 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52084470 |
| 130 | Phagosome_Homo sapiens_hsa04145 | 0.50078783 |
| 131 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49085167 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47651996 |
| 133 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46276349 |
| 134 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.46121607 |
| 135 | Tight junction_Homo sapiens_hsa04530 | 0.45107462 |
| 136 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42180087 |
| 137 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40876116 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39651674 |
| 139 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38918696 |
| 140 | Lysine degradation_Homo sapiens_hsa00310 | 0.37402584 |
| 141 | Taste transduction_Homo sapiens_hsa04742 | 0.36654229 |
| 142 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.34447748 |
| 143 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33624245 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30593245 |
| 145 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.29858366 |

